Skip to main content

Peer Review reports

From: Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by N-acetylcysteine

Original Submission
18 Mar 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
26 Oct 2016 Editorially accepted
18 Nov 2016 Article published 10.1186/s12885-016-2930-9

You can find further information about peer review here.

Back to article page